Market closedNon-fractional

Pyxis Oncology/PYXS

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Pyxis Oncology

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

Ticker

PYXS

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Boston, United States

Employees

51

Pyxis Oncology Metrics

BasicAdvanced
$185M
Market cap
-
P/E ratio
-$1.32
EPS
1.33
Beta
-
Dividend rate
$185M
1.33
12.19
11.67
10.729
11.283
-19.95%
-34.37%
8.563
1
1.15
-2.059
-59.01%
-68.32%

What the Analysts think about Pyxis Oncology

Analyst Ratings

Majority rating from 7 analysts.
Buy

Pyxis Oncology Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-19.87% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$16M
∞%
Net income
-$3.2M
-79.35%
Profit margin
-19.87%
-∞%

Pyxis Oncology Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 75.21%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.41
-$0.56
-$0.33
-$0.06
-
Expected
-$0.65
-$0.51
-$0.48
-$0.24
-$0.32
Surprise
-36.68%
10.53%
-30.53%
-75.21%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Pyxis Oncology stock?

Pyxis Oncology (PYXS) has a market cap of $185M as of July 15, 2024.

What is the P/E ratio for Pyxis Oncology stock?

The price to earnings (P/E) ratio for Pyxis Oncology (PYXS) stock is 0 as of July 15, 2024.

Does Pyxis Oncology stock pay dividends?

No, Pyxis Oncology (PYXS) stock does not pay dividends to its shareholders as of July 15, 2024.

When is the next Pyxis Oncology dividend payment date?

Pyxis Oncology (PYXS) stock does not pay dividends to its shareholders.

What is the beta indicator for Pyxis Oncology?

Pyxis Oncology (PYXS) has a beta rating of 1.33. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Pyxis Oncology stock

Buy or sell Pyxis Oncology stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing